What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to publicly disclose CVS Corporation's earnings for the first quarter ended March 29, 2003, by attaching the related press release as an exhibit. This ensures timely and broad dissemination of the company's financial results to investors.

Where can I find the actual financial results for Q1 2003?

The actual financial results for the first quarter of 2003 are contained within the press release dated May 6, 2003, which is attached as Exhibit 99.1 to this 8-K filing.

Will the information in this 8-K be part of future CVS filings?

The information furnished under Item 9 (Regulation FD Disclosure) is generally not incorporated by reference into other SEC filings like registration statements unless specifically stated by the company. Investors should treat the press release content as current disclosure for the period it covers.

Who is David B. Rickard and what is his role?

David B. Rickard is identified as the Executive Vice President, Chief Financial Officer, and Chief Administrative Officer of CVS Corporation. He signed this 8-K report, indicating his responsibility for the financial disclosures made by the company.

CVS 8-K SEC Disclosure

Summary

CVS Corporation filed this Form 8-K on May 6, 2003, to report its first-quarter earnings for the period ended March 29, 2003. The primary purpose of this filing is to provide investors with access to the official earnings press release, which is attached as an exhibit. This allows for timely disclosure of the company's financial performance and operational highlights from the first quarter of 2003. While the 8-K itself is a procedural document, the attached press release contains the substantive financial information. Investors should refer to the press release for details on revenue, net income, earnings per share, and any forward-looking statements or strategic initiatives announced by CVS during that period. The filing also confirms the roles of key executives involved in the reporting, including the CFO.

Key Highlights

1CVS Corporation filed an 8-K on May 6, 2003, to announce its Q1 2003 earnings.
2The report includes a press release dated May 6, 2003, detailing Q1 financial results.
3The filing is made under Regulation FD (Fair Disclosure) to ensure broad public access to the information.
4The press release is incorporated by reference as Exhibit 99.1.
5David B. Rickard, EVP, CFO, and CAO, signed the report, confirming executive oversight.
6The filing provides the company's principal executive offices address and contact information.
7Information furnished under Item 9 will not be automatically incorporated into future SEC filings unless explicitly stated.

CVS HEALTH Corp 8-K Report (May 6, 2003)

Summary

Key Highlights

Frequently Asked Questions